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Abstract  
Introduction Colorectal cancer patients may be treated with several modalities and one of them is 
surgical treatment. Surgery in cancer patients is a risky procedure and may not always result in 
prolonged survival. Therefore, before receiving any recommended treatment, the patient’s 
prognosis has to be assessed and defined properly. Several methods are available to assess the 
prognosis of cancer patients; one of them is the prognostic nutritional index (PNI). 
Objective This study aimed to predict the survival of a colorectal cancer patient postoperatively 
by calculating the preoperative PNI score. 
Method Literature searching was done using inclusion and exclusion criteria on two databases, 
i.e. the PubMed and the Cochrane Library. The outcome was survival (disease-free survival, 
relapse-free survival, or overall survival). 
Results Five articles that address the clinical question were retrieved. All indicated that a patient 
with low PNI score (<44.5) had a shorter overall survival (HR between 1.92 and 3.98 with all p 
values were <0.05). 
Conclusion Pre-operative PNI score can be used to assess the overall survival of a colorectal cancer 
patient who underwent surgical resection. Patients with a PNI score > 44.5 had better survival than 
lower PNI score. 
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Clinical Scenario 
 
Mr. MR, aged 67 years old, was complaining to have 
bloating and incomplete bowel emptying in the last 
8 months. He might have 1-2 defecations per day but 
the consistency was soft or liquid for about ½ glass 
each stool; the color is pale yellow and might be 
accompanied by dark red blood. He denied having 
nausea or vomitus and no black stool. During this 
time, his food intake was unchanged but he felt that 
his clothing was getting looser. His family also told 
him that he was getting thinner. Mr. MR visited a 
doctor in Hospital K and underwent a complete 
laboratory check-up. The results at 2 weeks before 
coming to our clinic was as follows: Hb 9.6 g/dL, 
leukocyte count 8000/mm3, platelet count: 
200.000/uL, lymphocyte count 2000/m3, and 
albumin 2.8 g/dL. A tumor was found and a biopsy 
confirmed that it was ascending colon cancer 
T3N0M0. The doctor recommended complete 
surgical resection of the tumor, followed by 
chemotherapy if needed. The patient asked more 
time to think and to discuss with his family. His 
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family suggested him to find another doctor for 
another opinion. Therefore, Mr. MR came to this 
clinic to find a second opinion for the recommended 
surgical treatment. He asked how long his chance to 
live if he takes the procedure. 
Introduction 
 
Colorectal cancer is the third most common 
malignancies worldwide with mortality rate rank the 
second after lung cancer.1 According to 
GLOBOCAN 2018 database, over 1.8 million new 
colorectal cancer cases are estimated to occur in 
2018, with 1 mortality in 10 cases. The incidence of 
colorectal cancer in south-eastern Asia is 5-9% of all 
cancers,2 otherwise the incidence rate of colorectal 
cancer per 100.000 population in Indonesia is 19.1 
(men) and 15.6 (female).3 Colorectal cancer in 
Indonesia has increased sharply due to the changing 
pattern of eating habit towards a high fat-low fiber 
diet or a diet high in processed meat consumption. 
Surgical management is offered to the patient 
whenever feasible and may be followed by 
chemotherapy.4 Colorectal cancer has a high 
recurrence rate after surgery; this is an important 
consideration for clinicians when choosing the best 
treatment for the patient. Assessment of prognostic 
factor is needed to assist clinicians in selecting the 
right treatment and education for the patient.5 One 
of the prognostic factors that can be used is the 
prognostic nutritional index (PNI). It is calculated 
pre-operatively as follows: PNI = 10 x serum 
albumin (g/dL) + 0.005 x total lymphocyte count 
(per mm3). Assessment of PNI was first done by 
Onodera et al to predict patients who underwent 
gastrointestinal surgery (colorectal, gastric, 
hepatocelullar, pancreatic cancer).6 The PNI is a 
method to objectively assess the patient’s prognosis, 
which is relatively cheap and easy to use by the 
clinicians.  
Clinical Question 
P: Post-operative adult patient with colorectal 
cancer  
I: The Prognostic Nutritional Index (PNI) score 
C: - 
O: Post-operative survival 
Clinical question: How does the prognostic 
nutritional index predict the postoperative survival 
of colorectal cancer patients? 
 
Methods 
 
Strategy of Article Searching 
Literature searching was done on PubMed and 
Cochrane Library on October 9, 2018 (Table 1). 
 
Strategy of Article Selection 
Eligibility Criteria  
Article selection was based on the inclusion and 
exclusion criteria, which addressed the clinical 
question. The inclusion criteria were: 1) the study 
subjects were adult patients (aged > 18 years); 2) 
subjects were diagnosed as colorectal cancer of 
various stages and underwent surgical treatment; 3) 
the PNI calculation was done pre-operatively; 4) the 
study population was originated from Asia and 5) 
the cutoff PNI score was set between 44 and 46. The 
exclusion criteria were 1) non-English journal and 
2) no available full text. 
 
Method of Critical Appraisal 
Critical appraisal was done by all authors and by 
using the method of critical appraisal according to 
the Center of Evidence Based Medicine 
(www.cebm.net) for prognostic studies that has been 
modified in Indonesian language. 
 
Results 
 
Based on the results from the two databases and by 
assessing the inclusion and exclusion criteria, we 
obtained 5 eligible articles to be included as 
references for a critical appraisal (Figure 1). 
Selected articles were studies with cohort 
design, either prospective or retrospective. The 
number of study subjects should be more than 200 
patients in the adult group. Patients should be 
followed-up at least for 60 months. Study 
characteristics is shown in Table 2. All studies had a 
level of evidence of 2 that were individual cohort 
studies. All their results showed that low PNI score 
indicated a shorter overall survival. The validity 
criteria are given in Table 3. There was a report that 
did not meet the criteria of applicability and 
importance, i.e. the study by Park et al. 
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Discussion 
 
Mohri et al did a retrospective study by assessing 
patients who underwent colorectal cancer resection 
between January 2001 and December 2016 in the 
Department of Gastrointestinal Surgery at Mie 
University Hospital, Japan. The study involved 365 
subjects with colorectal cancer from stage I to IV. 
Blood test was done before surgery and was used to 
count PNI; the score was low if PNI <45. The study 
results showed that PNI score can be a good 
predictor of postoperative complication (OR = 1.58 
[95% CI 1.03 to 2.42]; p = 0.04) and overall survival 
(OR = 2.25 [95% CI 1.42 to 3.59]; p < 0.0001) of 
patients with colorectal cancer.5 
 Cao et al did a retrospective study in an 
institution in China under the National Health and 
Family Planning Commission. The study was held 
between January 2009 and January 2012 involving 
228 study subjects who underwent laparoscopic 
surgery in Beijing Hospital. Patients’ age ranged 
from 27 to 92 years old and was followed-up every 
3 months up to 2 years, then every 6 months up to 5 
years and annually afterwards until they died. The 
median follow-up was 47 months (ranging from 3 to 
82 months); the last follow-up was in December 
2015. Blood specimen for laboratory test was 
withdrawn just before surgery was performed. The 
median overall survival of patients with high PNI 
score (> 44.55) was 70.2 months (95% CI: 66.1 to 
74.2 months), whereas the median OS of patients 
with low PNI score (<44.55) was 47.1 months (95% 
 
 
Figure 1. PRISMA Flowchart 
 
Cochrane 
(n=3) 
PubMed 
(n=21) 
“Prognostic Nutritional Index” AND “outcome OR survival” AND postoperative 
AND colorectal cancer 
Studies included 
(n=5) 
Records screened 
(n=5) 
Inclusion criteria: 
- Adult patients 
- Colorectal cancer patients 
from various stages and 
underwent surgical 
resection 
- PNI was evaluated before 
surgery 
- Study population 
originated from Asia 
- The PNI cutoff was 44-46 
Exclusion criteria: 
- Non-English journal 
- Full text was not available 
Search date: 9 October 2018 
Records after duplicates 
removed (n=24) 
Full-text assessed for eligibility 
(n=5) 
Paper excluded: 
- Non-English journal 
(n=5) 
- PNI was evaluated after 
surgery (n=1) 
- Not from Asia (n=4) 
- Subjects did not 
underwent surgery (n=3) 
- Subjects did not 
underwent PNI assessment 
(n=3) 
- The PNI cutoff was not 
44-46 (n=2) 
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CI: 42.9 to 51.2 months). Multivariate analysis on 
postoperative severe complications resulted in an 
OR of 4.03 (95% CI 1.10 to 14.71]; p = 0.035.7 
Jian Hui et al6 and most of studies set the 
optimal cut off value of PNI at 45, according to 
receiver operating characteristic (ROC) analysis for 
5-year overall analysis. Patients in the low PNI 
consider to have a greater aggressive histological 
features of cancer.  
Tokunaga et al did a retrospective study in 
2017. The study enrolled 468 patients aged more 
than 18 years with primary colorectal cancer and 
underwent colectomy in Kumamoto University 
Hospital, Japan between March 2005 and August 
2014. Patients were then followed-up till July 31, 
2016, or death with a mean follow-up of 48.5 
months (ranged from 2 to 124 months). Blood test 
was done two weeks before surgery. The study 
results showed that PNI and modified Glasgow 
prognostic score (mGPS) were associated with 
overall survival and relapse-free survival (RFS). 
PNI score was low if <45. Multivariate analyses 
showed that PNI score on overall survival was HR = 
2.89 [95% CI 1.81 to 4.64]; p < 0.001; while PNI 
analysis on RFS was HR = 2.31 [95% CI 1.53 to 
3.48]; p < 0.001.8 
 Park et al did a retrospective study on 1035 
patients with a median age of 65 years old (ranging 
from 56 to 71 years old) in National University 
Hospital Seoul. Subjects were patients who 
underwent surgery for primary colorectal cancer 
between January 2002 and December 2010. Blood 
test was done 4 weeks before surgery. Follow-up 
was done every three months in the first two years, 
every 6 months for the next three years and then 
annually afterward. The median time of follow-up 
was 66 years (2 to 140 months). The study results 
show that the American Society of 
Anesthesiologists (ASA) score, age, tumor location, 
the number of lymph node involvement, vein 
invasion, perineural invasion, adjuvant therapy, and 
PNI were significant prognostic factors. The PNI 
score of <45.5 was predictive for disease-free 
survival (DFS) (HR = 1.534; 95% CI 1.065 to 2.211; 
p = 0.022) and overall survival (HR = 1.915; 95% 
CI 1.286 to 2.852]; p = 0.001.9 
Tokunaga et al in 2015 did a retrospective 
study on 556 patients with primary colorectal cancer 
underwent a colectomy at Kumamoto University 
Hospital, Japan, between March 2005 and August 
2014. Patients’ age ranged from 63 to 83 years. 
Laboratory test was done two weeks before surgery. 
Patients were followed-up till death or till November 
20, 2014, with a mean follow-up of 31.8 months (1 
to 104 months). The study results indicated that PNI 
score of <45.5 was an independent risk factor of 
postoperative complication (OR = 2.06; 95% CI 
1.22 to 3.50; p = 0.007) and overall survival (HR = 
3.98; 95% CI 2.38 to 6.89]; p < 0.001).10 
Predictor of survival is also determined by systemic 
inflammatory responses, reflected by lymphocyte-
to-monocyte ratio (LMR), neutrophil-to-monocyte 
ratio (NMR), platelet-to-lymphocyte ratio (PLR), 
and C-reactive protein (CRP). PNI had positive 
correlation with LMR (r= 0,483, p < 0,001), but 
negative correlation with NLR (r=-0,441, p < 0,001), 
PLR (r= -0,607, p < 0,001), and CRP level (r=-
0,333, p < 0,001). A low PNI was associated with 
short overall survival and disease free survival in 
patients with stage III C colon cancer but not in 
patients with stage III A or III B.  Patients with stage 
III C may have a higher tumor burden with more 
complex systemic pro inflammatory cytokines than 
those are with lower stage. Therefore, preoperative 
PNI has significantly correlated with immunological 
status.11  
In conclusion, based on the publications 
appraised in this evidence-based case reports, pre-
operative PNI score can assess the overall survival 
of postoperative patients with colorectal cancer of 
various stages, either laparoscopically or 
conventionally. The overall survival of colorectal 
cancer patients with PNI > 44.5 showed an HR 
between 1.92 and 3.98. The PNI score can also be 
used to assess DFS and postoperative complication. 
Thus, PNI should be evaluated before surgical 
treatment to predict the patient’s postoperative 
prognosis. If the PNI score is low (P< 44.5), the 
nutritional status should be improved (in terms of 
serum albumin level and lymphocyte count) before 
surgical treatment to prolong the patient’s survival. 
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Conflict of Interest Table 1. Terminology 
 
Database Terminology Hits Eligible 
PubMed (((((((prognostic nutritional index[MeSH Terms]) OR prognostic nutritional 
index[Title/Abstract])) AND ((colorectal cancer[MeSH Terms]) OR colorectal 
cancer[Title/Abstract])) AND ((postoperative[MeSH Terms]) OR 
postoperative[Title/Abstract])) AND ((((survival[Title/Abstract]) OR 
survival[MeSH Terms]) OR outcome[MeSH Terms]) OR 
outcome[Title/Abstract])) 
21 5 
Cochrane #1 (pni):ti,ab,kw OR (prognostic nutritional index):ti,ab,kw (Word variations 
have been searched) 
#2 MeSH descriptor: [Nutrition Assessment] explode all trees  
#3 #1 or #2 
#4 (outcome):ti,ab,kw OR (survival):ti,ab,kw (Word variations have been 
searched) 
# MeSH descriptor: [Colorectal Neoplasms] explode all trees  
#6 (colorectal cancer):ti,ab,kw  
#7 #5 or #6  
#8 (postoperative):ti,ab,kw OR (surgery):ti,ab,kw (Word variations have been 
searched)  
#9 #3 and #4 and #7 and #8 
3 0 
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Mohri Y, 
et al 
(2013)3 
Retrospetive 
Cohort 
 
Postoperative 
colorectal cancer 
patients  
365 n/a PNI Score - Overall survival >16 
Cao X, et 
al (2017)5 
Retrospetive 
Cohort 
 
Post-laparoscopic 
surgical 
colorectal cancer 
patients  
228 >18 PNI Score - 
Overall 
survival and 
complications 
47 (3-82) 
Tokunaga 
R, et al 
(2017)6 
Retrospetive 
Cohort 
 
Colorectal cancer 
patients who  
underwent 
surgical treatment  
468 >18 
Systemic 
inflammation 
scores and 
nutrition 
(NLR, 
prognostic 
index (PI), 
PLR, PNI) 
modified 
Glasgow 
prognostic 
score 
(mGPS) 
and TNM 
Overall 
survival 48.5 (2-124) 
Park BK, 
et al 
(2016)7 
Retrospetive 
Cohort 
 
Stage II A 
Colorectal cancer 
patients  
1035 56-71 
Systemic 
inflammation 
score (NLR, 
dNL PLR, 
PNI, and 
serum 
fibrinogen) 
- Overall survival 66 (2 - 140) 
Tokunaga 
R, et al 
(2015)8 
Retrospective 
Cohort  
Postoperative 
colorectal cancer 
patients 
556 63-83 PNI Score - 
Severe 
complications, 
recurrence, 
and overall 
survival 
31.8 (1-104) 
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Table 3. Validity criteria 
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Result Level of Evidence 
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Mohri Y, et al 
(2013)3 
+ + - + + + + + A 2 
Cao X, et al 
(2017)5 
+ + - + + + + + B 2 
Tokunaga R, et al 
(2017)6 
+/- + - + + + + + C 2 
Park BK, et al 
(2016)7 
+ + - + + + - - D 2 
Tokunaga R, et al 
(2015)8 
+ + - + + + + + E 2 
A. Subjects with low PNI was associated with low postoperative survival (p < 0,0001); 
B. Low PNI score is an independent factor associated with postoperative complication and overall survival of 
colorectal cancer patient (p < 0.001). 
C. PNI score and mGPS are independent prognostic factors for overall survival and relapse-free survival of 
postoperative colorectal cancer patients (p<0.001). The PNI score can predict the patient’s survival more 
clearly than the mGPS combined with TNM staging. 
D. PNI score can be used for overall survival of stage II colorectal cancer patients postoperatively (p = 0.001). 
E.  Subjects with PNI score < 45.5 had shorter overall survival (p < 0.001). 
 
Table 4. Relevance criteria 
 
Article Similarity Population 
Similarity determinant/ 
intervention/ indicators 
Similarity 
Outcome 
Mohri Y, et al (2013)3 + + + 
Cao X, et al (2017)5 + + + 
Tokunaga R, et al (2017)6 + + + 
Park BK, et al (2016)7 - + + 
Tokunaga R, et al (2015)8 + + + 
 
Table 5. Results from critical appraisal 
 
Study Outcome n HR 95% CI 
Mohri Y, et al (2013)3 Overall survival 365 2.29* 1.42 to 3.59 
Cao X, et al (2017)5 Overall survival and complications 228 70.2** 66.1 to 74.2 
Tokunaga R, et al (2017)6 Overall survival 468 2.89 1.81 to 4.64 
Park BK, et al (2016)7 Overall survival 1035 1.92 1.29 to 2.85 
Tokunaga R, et al (2015)8 Severe complications, recurrence and overall survival 556 3.98 2.38 to 6.89 
* Odds ratio; ** months; HR = hazard ratio; CI = confidence interval 
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which permits unrestricted use, distribution, and 
reproduction in any medium, provided you give 
appropriate credit to the original author(s) and the 
source, provide a link to the Creative Commons 
license, and indicate if changes were made. 
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